--- title: "Mansueto Trims MORN at $180 — Still Owns 37.5% Beneficially" type: news slug: mansueto-morn-form4-may-2026-37-percent-beneficial-stake canonical_url: https://13finsight.com/news/mansueto-morn-form4-may-2026-37-percent-beneficial-stake published_at: 2026-05-10T23:01:27.550Z updated_at: 2026-05-10T23:01:30.411Z author: Alex Rivera author_title: Breaking News Editor author_url: https://13finsight.com/authors/alex-rivera word_count: 849 locale: en source: 13F Insight --- # Mansueto Trims MORN at $180 — Still Owns 37.5% Beneficially > Joseph Mansueto's May 7 Form 4 sold across $171.77-$180.00 on Morningstar — but his 37.5% beneficial stake (14.9M shares) is intact, and his son holds another 9.5%. Joseph Mansueto, the founder and largest single shareholder of Morningstar, sold across a 20-line Form 4 filing on May 7, 2026 — accession 0001324069-26-000022 — at prices ranging from $171.77 to $180.00 per share. The Class A position behind the trades stood at 8,107,242 shares after the last execution of the day. The headline-friendly take is "founder selling at the highs." The filing-cabinet take is more interesting: Mansueto is still the company's largest beneficial owner at 37.5% per his most recent Schedule 13G/A (accession 0001104659-26-014323, 14,909,759 shares), and his son Daniel Mansueto holds another 9.5% via accession 0001104659-26-014328. The May 7 sales trim a tiny sliver of an otherwise intact, family-controlled cap table. That distinction matters because the institutional book around MORN behaves like a different stock once you back out the family-locked share count. Trading economics, options pricing, and any "founder is bailing" narrative all need to be read against the 47%-of-shares-out that Joseph and Daniel Mansueto hold collectively. The 8.1 million Class A shares the Form 4 settles to is the founder's directly held Class A surface — not the entire stake. What the Form 4 actually shows The May 7 file is a clean batch of 20 open-market sales, all coded S, executed across the trading day at progressively lower prints — $180.00 at the open of the sequence stepping down to $171.77 at the close of the sequence. None of the 20 lines carry a 10b5-1 footnote in the Form 4 metadata we ingest, which means the sales are presumed discretionary unless a corresponding plan-adoption disclosure is filed in the proxy or a separate exhibit. Mansueto's full transaction history shows 11,071 lifetime transactions and $1.95B in lifetime sell value — this is a long-running disposition pattern, not a one-off de-risking signal. What the Form 4 does not show: any change to the underlying voting structure or the Schedule 13G/A beneficial-ownership percentages. The 37.5% Joseph Mansueto figure (14,909,759 shares) was reaffirmed as of the most recent 13G/A refresh; the 8.1M Class A direct figure on the Form 4 sits inside that broader stake. Anyone reading the May 7 trade as an exit signal is reading the smaller of the two ownership layers. The institutional book around the founder MORN's Q4 2025 13F file shows a relatively concentrated active-manager bench: Morgan Stanley — $436M (a heavier weighting than the typical financial-data peer) Select Equity Group — $330.9M (long-duration active conviction) BAMCO Inc. — $269.9M (Baron-affiliated active manager) Wellington Management — $246.9M AQR Capital Management — $195.6M (factor/quant exposure) Los Angeles Capital — $109.1M JPMorgan Chase — $79.4M The presence of BlackRock at $513.6M and Vanguard Capital Management at $167.3M is index-mandate exposure rather than conviction. So is Jane Street Group at $94M (classified as market_maker in the platform's filer taxonomy and filtered out of smart-money surfaces). Where the file gets more interesting is the BAMCO + Select Equity + Wellington trio sitting alongside Mansueto's 37.5% — a buy-side cohort that reads like long-term holders comfortable being on the same side of the trade as the founder. The "founder selling at the highs" framing — and why it's incomplete The temptation on a $171–180 print is to read Mansueto's May 7 sequence as a cycle-high de-risking. Two correctives: The disposition cadence has been multi-year. 11,071 lifetime transactions and a $1.95B lifetime sell figure means the May 7 print is one batch in a long-running diversification program, not an inflection. Treating it as bearish requires evidence of an acceleration that the lifetime curve does not yet support. The 37.5% beneficial stake didn't move. A founder unwinding their conviction would be filing 13D/A amendments cutting the percentage, restructuring the trust holdings, or filing a 144 notice for a programmatic large-block disposal. None of those corresponding filings appear in the Q2 2026 EDGAR record. The May 7 Class A trim is at the edge of the position, not the structure. What's actually next to verify Morningstar's Q1 2026 earnings disclosure (already published April 30, 2026 — confirm the May 7 sale window opened post-earnings, not pre). If the sales hit inside an open window, the discretionary-vs-plan question gets cleaner. If they hit inside a blackout, the next 10-Q's risk-and-controls disclosure will need to address it. The next 13G/A from Joseph Mansueto. Beneficial-ownership amendments file within 10 days of any cumulative 1% threshold cross. A 37.5% stake that drops to 36.4% is the level at which the founder-control framing changes; until then, it's noise on the Class A surface. The next 13F cycle (August 14, 2026 deadline for Q2 2026) — watch Select Equity Group and BAMCO. If the long-duration active book trims into Mansueto's selling, that's the institutional confirmation of a regime change. If they hold or add, the May 7 file is exactly what it looks like — a founder taking some money off a Class A surface while the structural position stays intact. You can pull Joseph Mansueto's full Form 4 history and the complete MORN institutional table (including the 47% combined Mansueto-family beneficial ownership context) directly from the platform. The smart-money signal feed aggregates the active-manager moves first. ## FAQ ### How much MORN did Joseph Mansueto sell on May 7? Mansueto filed a 20-line Form 4 on May 7, 2026 (accession 0001324069-26-000022) selling Morningstar Class A shares across a price range of $171.77 to $180.00. The directly-held Class A position after the last execution was 8,107,242 shares. ### Does Joseph Mansueto still own Morningstar? Yes. Mansueto remains the largest single beneficial owner of MORN at 37.5% (14,909,759 shares) per his most recent Schedule 13G/A (accession 0001104659-26-014323). His son Daniel Mansueto holds an additional 9.5%, putting the family stake at roughly 47% of shares outstanding. ### Were the May 7 MORN sales under a 10b5-1 plan? The 20 transaction lines on the May 7 Form 4 do not carry a 10b5-1 plan footnote in the public filing metadata. The sales are presumed discretionary unless a corresponding plan-adoption disclosure appears in the proxy or a separate exhibit. ### Who are the largest active institutional holders of Morningstar? MORN's top active institutional holders include Morgan Stanley at $436M, Select Equity Group at $330.9M, BAMCO Inc at $269.9M, Wellington Management at $246.9M, and AQR Capital Management at $195.6M. The active book sits alongside Mansueto's 37.5% beneficial stake. --- Source: 13F Insight — https://13finsight.com/news/mansueto-morn-form4-may-2026-37-percent-beneficial-stake Author: Alex Rivera — https://13finsight.com/authors/alex-rivera Last updated: 2026-05-10T23:01:30.411Z